Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
T cell chemokine receptor patterns as pathogenic signatures in autoimmunity.
Why some of us do not like the expression "no evidence of disease activity" (NEDA) in multiple sclerosis.
Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait.
Aminopropyl carbazole analogues as potent enhancers of neurogenesis.
Autophagy-related gene16L2, a potential serum biomarker of multiple sclerosis evaluated by bead-based proteomic technology.
Nervous system involvement of connective tissue disease: mechanisms and diagnostic approach.
Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status.
An electrophysiological classification associated with Guillain-Barré syndrome outcomes.
Why are prions and amyloid structures immune suppressive and other intriguing questions facing neuroimmunologists in the future.
Vaccines and multiple sclerosis: a systematic review.
A simple procedure for the extraction of DNA from long-term formalin-preserved brain tissues for the detection of EBV by PCR.
Ranking of Disease-Modifying Therapies for Multiple Sclerosis.
Auditory deficits in neurological disorders.
The expression of PLP/DM-20 mRNA is restricted to the oligodendrocyte-lineage cells in the adult rat spinal cord.
Neurostereology protocol for unbiased quantification of neuronal injury and neurodegeneration.
Methylprednisolone induced liver injury: Case report and literature review.
Quetiapine Inhibits Microglial Activation by Neutralizing Abnormal STIM1-Mediated Intercellular Calcium Homeostasis and Promotes Myelin Repair in a Cuprizone-Induced Mouse Model of Demyelination.
Frequency of myasthenia gravis in multiple sclerosis: Report of five cases from Isfahan, Iran.
Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression.
Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis.
Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis.
[Collaborative networks between Spain and Latin America regarding multiple sclerosis].
Biological role of Toll-like receptor-4 in the brain.
Patch-Based Segmentation with Spatial Consistency: Application to MS Lesions in Brain MRI.
[Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children].
Pages
« first
‹ previous
…
683
684
685
686
687
688
689
690
691
…
next ›
last »